Penicillins and Cell-Wall-Synthesis Inhibitors
β-Lactams, Glycopeptides & Non-β-Lactam Wall Agents — Mechanism, Resistance & Clinical Use
Past RGUHS + DNB + MPMSU + MUHS · 12
RGUHSSep '25
MPMSUJan '25
RGUHSJun '24
MUHSWinter '23
MUHSSummer '21
DNBDec '21
RGUHSJun '16
MPMSU2016
DNBDec '12
MPMSU2011
MPMSU2011
RGUHSMay '10
Introduction
- Cell-wall-synthesis inhibitors block assembly of the bacterial peptidoglycan (murein) wall — the rigid heteropolymer that resists the cell's high internal osmotic pressure; peptidoglycan and its D-alanine chemistry are unique to bacteria, giving these drugs their selective toxicity.
- The β-lactam antibiotics — penicillins, cephalosporins, carbapenems and the monobactam aztreonam — share a β-lactam ring and a common mechanism (inhibition of peptidoglycan cross-linking); they are the single most important antibacterial class.
- Non-β-lactam wall/membrane agents covered here: glycopeptides (vancomycin, teicoplanin), lipoglycopeptides (telavancin, dalbavancin, oritavancin), the lipopeptide daptomycin, and bacitracin.
- Prototype natural penicillin = benzylpenicillin (penicillin G), discovered 1941; near-nontoxic to humans (up to 20 MU/day without organ toxicity).
- Cephalosporins are a separate topic and appear here only in overview for β-lactam-family completeness.
Continue reading
Penicillins
PharmaNotes Pro · LAQ
Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.